{"name":"Triathlon Medical Venture Partners","permalink":"triathlon-medical-venture-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/triathlon-medical-venture-partners","homepage_url":"http://www.tmvp.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"513-723-2600","description":"Investing in Biomedical Innovation","email_address":"info@tmvp.com","number_of_employees":null,"founded_year":2004,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Mon Mar 30 22:17:45 UTC 2009","updated_at":"Mon Aug 03 22:34:09 UTC 2009","overview":"<p>Whether you&#8217;re an entrepreneur or a venture capitalist, you&#8217;ll find a warm welcome at Triathlon Medical Ventures. Prior to opening our doors in 2004, Triathlon&#8217;s team has been investing in life science business opportunities for more than fifteen years. And we are also industry veterans, experienced at growing medical device and biotechnology companies from the inside out - as owners, directors and operational managers.</p>\n\n<p>Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. We provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs. </p>","image":{"available_sizes":[[[150,12],"assets/images/resized/0004/5663/45663v1-max-150x150.png"],[[250,20],"assets/images/resized/0004/5663/45663v1-max-250x250.png"],[[450,36],"assets/images/resized/0004/5663/45663v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"250 East Fifth Street","address2":" 1100 Chiquita Center","zip_code":"45202","city":"Cincinnati","state_code":"OH","country_code":"USA","latitude":39.101962,"longitude":-84.508978}],"relationships":[{"is_past":false,"title":"Founder and Managing Partner ","person":{"first_name":"John","last_name":"M. Rice","permalink":"john-m-rice","image":{"available_sizes":[[[119,150],"assets/images/resized/0004/5666/45666v1-max-150x150.jpg"],[[135,169],"assets/images/resized/0004/5666/45666v1-max-250x250.jpg"],[[135,169],"assets/images/resized/0004/5666/45666v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Co-founder and Managing Partner","person":{"first_name":"Dennis","last_name":"B. Costello","permalink":"dennis-b-costello","image":{"available_sizes":[[[119,150],"assets/images/resized/0004/5664/45664v1-max-150x150.jpg"],[[135,169],"assets/images/resized/0004/5664/45664v1-max-250x250.jpg"],[[135,169],"assets/images/resized/0004/5664/45664v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Partner","person":{"first_name":"Suzette","last_name":"Dutch","permalink":"suzette-dutch","image":{"available_sizes":[[[119,150],"assets/images/resized/0004/5665/45665v1-max-150x150.jpg"],[[135,169],"assets/images/resized/0004/5665/45665v1-max-250x250.jpg"],[[135,169],"assets/images/resized/0004/5665/45665v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"f","source_url":"http://www.fiercebiotech.com/story/biovex-raises-40m-series-f/2009-03-30","source_description":"BioVex Raises $40 Million","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":30,"company":{"name":"BioVex","permalink":"biovex","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9487/49487v2-max-150x150.jpg"],[[250,68],"assets/images/resized/0004/9487/49487v2-max-250x250.jpg"],[[294,80],"assets/images/resized/0004/9487/49487v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Capital Funding Report","raised_amount":null,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":16,"company":{"name":"Tolera Therapeutics","permalink":"tolera-therapeutics","image":{"available_sizes":[[[138,79],"assets/images/resized/0004/5655/45655v1-max-150x150.jpg"],[[138,79],"assets/images/resized/0004/5655/45655v1-max-250x250.jpg"],[[138,79],"assets/images/resized/0004/5655/45655v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/akebia-therapeutics-inc-series-a-16m/","source_description":"Akebia Therapeutics, Inc.: Series A $16M","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":15,"company":{"name":"Akebia Therapeutics","permalink":"akebia-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0006/0146/60146v1-max-150x150.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-250x250.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.ceresventurefund.com/pr7.pdf","source_description":"Ceres Venture Fund Invests in $6.25 Million Series A Round for Cancer-Specific Biomarker Company CS-Keys, Inc.","raised_amount":6250000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":25,"company":{"name":"CS-Keys","permalink":"cs-keys","image":{"available_sizes":[[[150,77],"assets/images/resized/0007/0307/70307v1-max-150x150.jpg"],[[213,110],"assets/images/resized/0007/0307/70307v1-max-250x250.jpg"],[[213,110],"assets/images/resized/0007/0307/70307v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/endocyte-inc-series-c-26m/","source_description":"Endocyte, Inc.: Series C $26M","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":19,"company":{"name":"Endocyte","permalink":"endocyte","image":{"available_sizes":[[[150,74],"assets/images/resized/0007/4250/74250v1-max-150x150.png"],[[193,96],"assets/images/resized/0007/4250/74250v1-max-250x250.png"],[[193,96],"assets/images/resized/0007/4250/74250v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.akebia.com/news/Akebia_Srs_B_Financing.pdf","source_description":"AKEBIA COMPLETES $22M SERIES B FINANCING","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":26,"company":{"name":"Akebia Therapeutics","permalink":"akebia-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0006/0146/60146v1-max-150x150.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-250x250.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.prnewswire.com/news-releases/colucid-pharmaceuticals-raises-75-million-of-planned-95-million-128664483.html","source_description":"CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":30,"company":{"name":"CoLucid Pharmaceuticals","permalink":"colucid-pharmaceuticals","image":{"available_sizes":[[[150,57],"assets/images/resized/0015/1961/151961v1-max-150x150.png"],[[210,81],"assets/images/resized/0015/1961/151961v1-max-250x250.png"],[[210,81],"assets/images/resized/0015/1961/151961v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/01/akebia-therapeutics-raises-4-1m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Akebia Therapeutics Raises $4.1M in Series B Financing","raised_amount":4100000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":9,"company":{"name":"Akebia Therapeutics","permalink":"akebia-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0006/0146/60146v1-max-150x150.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-250x250.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/05/mitralign-closes-35m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Mitralign Closes $35M in Series D Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":16,"company":{"name":"Mitralign","permalink":"mitralign","image":{"available_sizes":[[[150,63],"assets/images/resized/0019/0150/190150v1-max-150x150.png"],[[184,78],"assets/images/resized/0019/0150/190150v1-max-250x250.png"],[[184,78],"assets/images/resized/0019/0150/190150v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/07/juventas-therapeutics-closes-22-2m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Juventas Therapeutics Closes $22.2M Series B Financing","raised_amount":22200000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":16,"company":{"name":"Juventas Therapeutics","permalink":"juventas-therapeutics","image":{"available_sizes":[[[150,66],"assets/images/resized/0013/2328/132328v1-max-150x150.jpg"],[[196,87],"assets/images/resized/0013/2328/132328v1-max-250x250.jpg"],[[196,87],"assets/images/resized/0013/2328/132328v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/08/aerpio-therapeutics-closes-27m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Aerpio Therapeutics Closes $27M Series A Financing","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":30,"company":{"name":"Aerpio Therapeutics","permalink":"aerpio-therapeutics","image":{"available_sizes":[[[97,65],"assets/images/resized/0020/9041/209041v1-max-150x150.png"],[[97,65],"assets/images/resized/0020/9041/209041v1-max-250x250.png"],[[97,65],"assets/images/resized/0020/9041/209041v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.prnewswire.com/news-releases/tolera-therapeutics-closes-series-b-3-financing-raises-55-million-to-submit-phase-3-special-protocol-assessment-for-its-immune-targeting-biologic-drug-in-kidney-transplantation-174443781.html","source_description":"Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation PR Newswire","raised_amount":5500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":16,"company":{"name":"Tolera Therapeutics","permalink":"tolera-therapeutics","image":{"available_sizes":[[[138,79],"assets/images/resized/0004/5655/45655v1-max-150x150.jpg"],[[138,79],"assets/images/resized/0004/5655/45655v1-max-250x250.jpg"],[[138,79],"assets/images/resized/0004/5655/45655v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}